Mark Blumling

Mark Blumling

Director/Board Member at Data Cubed LLC

Health Technology
Commercial Services
Consumer Services

Profile

Mark Blumling was the founder of Hyperion Therapeutics, Inc. (founded in 2006) and Headlands Research, Inc. (founded in 2018), where he held the titles of Chief Operating Officer and President, Chief Executive Officer & Director, respectively.
Currently, he is a Director at Data Cubed LLC since 2023.
Mr. Blumling's former positions include Chief Executive Officer at RedBrick Health Corp., Relevare Aust Pty Ltd., and Relevare Pharmaceuticals Ltd., Chief Executive Officer at Genos Research, Inc., Director-Strategy & Business Development at Orchid Cellmark, Inc., and Director at Signature Therapeutics, Inc., Burrill LLC, and GlaxoSmithKline LLC.
Mr. Blumling's education includes an undergraduate degree from Stanford University, a graduate degree from the London School of Economics & Political Science, and a graduate degree from Stanford Law School.

Mark Blumling active positions

CompaniesPositionStart
Director/Board Member 08/02/2023
All active positions of Mark Blumling

Former positions of Mark Blumling

CompaniesPositionEnd
Chief Executive Officer -
Director/Board Member -
Founder -
Chief Executive Officer -
Director/Board Member -
See the detail of Mark Blumling's experience

Training of Mark Blumling

Stanford University Undergraduate Degree
London School of Economics & Political Science Graduate Degree
Stanford Law School Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Blumling's experience

Connections

6

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies11

Commercial Services

Health Technology

Health Technology

Finance

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Technology Services

See company connections